Accurate, rapid, point-of-care tests for sexually transmitted infections.

[1]  Michael R. Wierzbicki,et al.  Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study. , 2020, The Lancet. Infectious diseases.

[2]  M. Unemo,et al.  2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. , 2020, International journal of STD & AIDS.

[3]  M. Unemo,et al.  Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus , 2020, PloS one.

[4]  N. Low,et al.  Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis. , 2020, The Lancet. Infectious diseases.

[5]  R. Peeling,et al.  Call to action for health systems integration of point-of-care testing to mitigate the transmission and burden of sexually transmitted infections , 2020, Sexually Transmitted Infections.

[6]  I. Martin,et al.  World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. , 2019, Sexual health.

[7]  M. Unemo,et al.  Diagnosing sexually transmitted infections in resource‐constrained settings: challenges and ways forward , 2019, Journal of the International AIDS Society.

[8]  N. Low,et al.  Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016 , 2019, Bulletin of the World Health Organization.

[9]  N. Low,et al.  Prevalence of Mycoplasma genitalium in different population groups: systematic review andmeta-analysis , 2017, Sexually Transmitted Infections.

[10]  N. Low,et al.  Detection of antibiotic resistance is essential for gonorrhoea point-of-care testing: a mathematical modelling study , 2017, BMC Medicine.